← Study Library
In vitro · 2011
Preclinicalcounts toward this tierThymosin beta 4 induces colon cancer cell migration and clinical metastasis via enhancing ILK/IQGAP1/Rac1 signal transduction pathway
Tang MC, Chan LC, Yeh YC, Chen CY, Chou TY, Wang WS, Su Y · Cancer Letters
Preclinicalcounts toward this tier
Overexpression raised Rac1 activity and IQGAP1/ILK complex levels and increased migration; knocking Tβ4 down lowered both proteins and the cells' migratory capacity, with the same pattern seen in patient tissue.
- Population
- Tβ4-overexpressing SW480 colon cancer cells; patient tumour immunohistochemistry
- Intervention
- Tβ4 overexpression and knockdown
- Comparator
- Parental and non-targeting-knockdown cells
- Limitations
- Single cell line, one research group; the patient component is immunohistochemical correlation.
Cited by
1 entry references this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental